CAT
Caterpillar Inc.
CAT has lower modeled downside risk, despite its lower overall score.
GNK
Genco Shipping & Trading Limited
GNK has a slight edge over CAT overall, supported by stronger fundamentals and stronger valuation.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
GNK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Healthy |
GNK's revenue, profitability, cash flow and balance sheet are all currently healthy.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over GNK in the historical PE scenario, which offers more potential upside but is not a forecast.
GNK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4x | $7.24 | -73% |
| Fair | 10x | $18.34 | -31% |
| Forward | 10x | $26.41 | — |
| Current | 15x | $26.41 | — |
| Expensive | 56x | $100 | +280% |
Historical ranges are pointers, not guarantees.
GNK's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 10x next year's earnings.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
GNK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for GNK, with profitability improving. However, they disagree widely on these estimates.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
GNK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.55 | +42% |
| Q3 2026 | $1.79 | +$1.96 |
| Q2 2026 | $0.92 | +171% |
| Q1 2026 | $0.39 | -63% |
| Q4 2025 | -$0.10 | -106% |
| Q3 2025 | -$0.17 | -111% |
| Q2 2025 | $0.34 | 0% |
| Q1 2025 | $1.04 | +1386% |
| Q4 2024 | $1.75 | +$2.05 |
GNK has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over GNK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT's operating margin was 20% last quarter, up 3.1 points from the same quarter a year ago.
GNK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $151.9M | +90% |
| Q2 2026 | $136.4M | +69% |
| Q1 2026 | $114.4M | +61% |
| Q4 2025 | $109.9M | +11% |
| Q3 2025 | $79.9M | -20% |
| Q2 2025 | $80.9M | -24% |
| Q1 2025 | $71.3M | -39% |
| Q4 2024 | $99.2M | -14% |
GNK's revenue is recovering but still below its 2021 peak: $152M last quarter, up 90% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 29% | +26 points |
| Q2 2026 | 16% | +21 points |
| Q1 2026 | 12% | +25 points |
| Q4 2025 | 17% | +2.6 points |
| Q3 2025 | 3.1% | -21 points |
| Q2 2025 | -5.3% | -30 points |
| Q1 2025 | -14% | -33 points |
| Q4 2024 | 15% | +8.6 points |
GNK has the edge over CAT on profitability, with a higher operating margin.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over GNK on cash flow, with more consistent year-over-year improvement.
GNK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $65.4M | +902% |
| Q2 2026 | $32.5M | +652% |
| Q1 2026 | $15.3M | +579% |
| Q4 2025 | $15.6M | -47% |
| Q3 2025 | $6.5M | -81% |
| Q2 2025 | $4.3M | -84% |
| Q1 2025 | $2.3M | -93% |
| Q4 2024 | $29.3M | -25% |
GNK still generates free cash flow, though less than at its 2021 peak: $129M over the past year.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over GNK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
GNK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +62.2K shares |
| 1 year | +2.8% | +1.2M shares |
| 3 years | +4.2% | +1.8M shares |
| 5 years | +4.4% | +1.9M shares |
| Available history | +6.3% | +2.6M shares |
GNK has 45M diluted shares, up 2.8% from a year ago.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over GNK on leverage, with a lower net debt burden relative to earnings.
GNK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 2.4x | Moderate |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.9x | Very low |
| Q2 2025 | 0.6x | Very low |
| Q1 2025 | 0.4x | Very low |
| Q4 2024 | 0.3x | Very low |
GNK's net debt is about 1.5 years of its operating earnings (EBITDA), up from less than a year a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
GNK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.1 | Neutral |
| Stochastic | 48.7 | Neutral |
GNK's weekly RSI is 54 (neutral) and its Stochastic is 49 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
GNK PE vs Industrials Sector
| Metric | GNK | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 24x | 39% below |
| PE % | 56 | 58 | 2 pts below |
GNK has the edge over CAT on valuation relative to its sector.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
GNK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.1 | 1.1% above |
| 20 week MA | $26.1 | 1.2% above |
| 50 week MA | $23.7 | 11% above |
| 100 week MA | $19.4 | 36% above |
| 200 week MA | $18.2 | 45% above |
GNK has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
GNK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.6 | $7.24 | -32% |
| 2021 | $7.24 | $15.3 | +111% |
| 2022 | $15.3 | $15.6 | +1.8% |
| 2023 | $15.6 | $16.6 | +6.7% |
| 2024 | $16.6 | $13.9 | -16% |
| 2025 | $13.9 | $18.8 | +35% |
| 2026 YTD | $18.8 | $26.4 | +41% |
GNK has the edge over CAT on returns for 2026, with the stronger performance.